These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8382913

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Immunocytochemical localization of macrophage migration inhibitory factor in human hypophysis and pituitary adenomas.
    Tampanaru-Sarmesiu A, Stefaneanu L, Thapar K, Kovacs K, Donnelly T, Metz CN, Bucala R.
    Arch Pathol Lab Med; 1997 Apr; 121(4):404-10. PubMed ID: 9140312
    [Abstract] [Full Text] [Related]

  • 3. Immunocytochemical localization of synaptophysin in human hypophyses and pituitary adenomas.
    Stefaneanu L, Ryan N, Kovacs K.
    Arch Pathol Lab Med; 1988 Aug; 112(8):801-4. PubMed ID: 3134875
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Crooke's hyalinization in silent corticotroph adenoma: report of two cases.
    Roncaroli F, Faustini-Fustini M, Mauri F, Asioli S, Frank G.
    Endocr Pathol; 2002 Aug; 13(3):245-9. PubMed ID: 12446925
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical demonstration of tenascin in human pituitary glands and adenomas.
    Ikeda H, Yoshimoto T, Fujiwara K, Ogawa Y.
    Acta Histochem; 1995 Jul; 97(3):273-80. PubMed ID: 8525784
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cytokeratin CK20 is a sensitive marker for Crooke's cells and the early cytoskeletal changes associated with hypercortisolism within pituitary corticotrophs.
    Eschbacher JM, Coons SW.
    Endocr Pathol; 2006 Jul; 17(4):365-76. PubMed ID: 17525485
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma.
    George DH, Scheithauer BW, Kovacs K, Horvath E, Young WF, Lloyd RV, Meyer FB.
    Am J Surg Pathol; 2003 Oct; 27(10):1330-6. PubMed ID: 14508394
    [Abstract] [Full Text] [Related]

  • 12. Pituitary tumors and hyperplasia in multiple endocrine neoplasia type 1 syndrome (MEN1): a case-control study in a series of 77 patients versus 2509 non-MEN1 patients.
    Trouillas J, Labat-Moleur F, Sturm N, Kujas M, Heymann MF, Figarella-Branger D, Patey M, Mazucca M, Decullier E, Vergès B, Chabre O, Calender A, Groupe d'études des Tumeurs Endocrines.
    Am J Surg Pathol; 2008 Apr; 32(4):534-43. PubMed ID: 18300794
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fibrous bodies are associated with lower GH production and decreased expression of E-cadherin in GH-producing pituitary adenomas.
    Nishioka H, Haraoka J, Akada K.
    Clin Endocrinol (Oxf); 2003 Dec; 59(6):768-72. PubMed ID: 14974920
    [Abstract] [Full Text] [Related]

  • 19. p75 and TrkC neurotrophin receptors demonstrate a different immunoreactivity profile in comparison to TrkA and TrkB receptors in human normal pituitary gland and adenomas.
    Assimakopoulou M, Zolota V, Chondrogianni C, Gatzounis G, Varakis J.
    Neuroendocrinology; 2008 Dec; 88(2):127-34. PubMed ID: 18319596
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.